Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LSD1-IN-30 is a lysine-specific demethylase 1 (LSD1) inhibitor with anticancer activity for the study of small cell lung cancer and acute myeloid leukemia.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 118.00 | |
5 mg | In stock | $ 297.00 | |
10 mg | In stock | $ 475.00 | |
25 mg | In stock | $ 953.00 | |
50 mg | In stock | $ 1,530.00 | |
100 mg | In stock | $ 2,450.00 |
Description | LSD1-IN-30 is a lysine-specific demethylase 1 (LSD1) inhibitor with anticancer activity for the study of small cell lung cancer and acute myeloid leukemia. |
Targets&IC50 | LSD1:0.291 μM |
Molecular Weight | 270.28 |
Formula | C15H14N2O3 |
CAS No. | 1289575-45-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 80 mg/mL (295.99 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
LSD1-IN-30 1289575-45-6 Chromatin/Epigenetic Histone Demethylase LSD1IN30 inhibitor inhibit